T Scientific Co.Ltd (057680) - Net Assets
Based on the latest financial reports, T Scientific Co.Ltd (057680) has net assets worth ₩140.08 Billion KRW (≈ $94.93 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩161.30 Billion ≈ $109.31 Million USD) and total liabilities (₩21.22 Billion ≈ $14.38 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 057680 financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩140.08 Billion |
| % of Total Assets | 86.84% |
| Annual Growth Rate | 14.45% |
| 5-Year Change | 67.64% |
| 10-Year Change | 1168.98% |
| Growth Volatility | 78.93 |
T Scientific Co.Ltd - Net Assets Trend (2009–2024)
This chart illustrates how T Scientific Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 057680 asset base for the complete picture of this company's asset base.
Annual Net Assets for T Scientific Co.Ltd (2009–2024)
The table below shows the annual net assets of T Scientific Co.Ltd from 2009 to 2024. For live valuation and market cap data, see 057680 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩140.32 Billion ≈ $95.09 Million |
+7.48% |
| 2023-12-31 | ₩130.55 Billion ≈ $88.47 Million |
-26.65% |
| 2022-12-31 | ₩177.97 Billion ≈ $120.61 Million |
-19.79% |
| 2021-12-31 | ₩221.89 Billion ≈ $150.37 Million |
+165.10% |
| 2020-12-31 | ₩83.70 Billion ≈ $56.72 Million |
+54.19% |
| 2019-12-31 | ₩54.29 Billion ≈ $36.79 Million |
+71.63% |
| 2018-12-31 | ₩31.63 Billion ≈ $21.43 Million |
+237.57% |
| 2017-12-31 | ₩9.37 Billion ≈ $6.35 Million |
+21.01% |
| 2016-12-31 | ₩7.74 Billion ≈ $5.25 Million |
-29.98% |
| 2015-12-31 | ₩11.06 Billion ≈ $7.49 Million |
-14.54% |
| 2014-12-31 | ₩12.94 Billion ≈ $8.77 Million |
+13.62% |
| 2013-12-31 | ₩11.39 Billion ≈ $7.72 Million |
-30.32% |
| 2010-12-31 | ₩16.34 Billion ≈ $11.08 Million |
-11.83% |
| 2009-12-31 | ₩18.54 Billion ≈ $12.56 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to T Scientific Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 19518.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩35.72 Billion | 25.45% |
| Other Components | ₩176.55 Billion | 125.82% |
| Total Equity | ₩140.32 Billion | 100.00% |
T Scientific Co.Ltd Competitors by Market Cap
The table below lists competitors of T Scientific Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
OptimumBank Holdings, Inc.
NYSE MKT:OPHC
|
$66.92 Million |
|
GeeCee Ventures Limited
NSE:GEECEE
|
$66.93 Million |
|
Pharol SGPS SA
LS:PHR
|
$66.94 Million |
|
Lautan Luas Tbk
JK:LTLS
|
$66.94 Million |
|
Trinity Precision Technology Co Ltd
TWO:4534
|
$66.85 Million |
|
SLP Resources Bhd
KLSE:7248
|
$66.85 Million |
|
CUE Energy Resources Ltd
AU:CUE
|
$66.84 Million |
|
Dongyang Expre
KO:084670
|
$66.83 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in T Scientific Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 131,228,856,380 to 140,318,401,090, a change of 9,089,544,710 (6.9%).
- Net income of 2,223,445,020 contributed positively to equity growth.
- Share repurchases of 2,989,818,630 reduced equity.
- New share issuances of 2,989,818,630 increased equity.
- Other factors increased equity by 6,866,099,690.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩2.22 Billion | +1.58% |
| Share Repurchases | ₩2.99 Billion | -2.13% |
| Share Issuances | ₩2.99 Billion | +2.13% |
| Other Changes | ₩6.87 Billion | +4.89% |
| Total Change | ₩- | 6.93% |
Book Value vs Market Value Analysis
This analysis compares T Scientific Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.50x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.23x to 1.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩359.84 | ₩2960.00 | x |
| 2017-12-31 | ₩374.63 | ₩2960.00 | x |
| 2018-12-31 | ₩943.81 | ₩2960.00 | x |
| 2019-12-31 | ₩1346.74 | ₩2960.00 | x |
| 2020-12-31 | ₩1794.62 | ₩2960.00 | x |
| 2021-12-31 | ₩4687.91 | ₩2960.00 | x |
| 2022-12-31 | ₩3220.48 | ₩2960.00 | x |
| 2023-12-31 | ₩1953.05 | ₩2960.00 | x |
| 2024-12-31 | ₩1969.42 | ₩2960.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently T Scientific Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.58%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.17%
- • Asset Turnover: 0.26x
- • Equity Multiplier: 1.16x
- Recent ROE (1.58%) is above the historical average (-20.35%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 3.81% | 5.58% | 0.36x | 1.88x | ₩-841.16 Million |
| 2013 | -42.10% | -55.35% | 0.35x | 2.15x | ₩-5.93 Billion |
| 2014 | 7.94% | 4.08% | 1.11x | 1.75x | ₩-267.16 Million |
| 2015 | -21.10% | -6.30% | 1.47x | 2.28x | ₩-3.44 Billion |
| 2016 | -140.02% | -36.41% | 1.30x | 2.96x | ₩-11.62 Billion |
| 2017 | -50.36% | -85.94% | 0.12x | 4.83x | ₩-5.66 Billion |
| 2018 | 7.40% | 44.86% | 0.07x | 2.23x | ₩-823.91 Million |
| 2019 | 9.75% | 68.79% | 0.10x | 1.44x | ₩-138.17 Million |
| 2020 | 0.78% | 6.85% | 0.09x | 1.30x | ₩-7.72 Billion |
| 2021 | -1.42% | -31.36% | 0.03x | 1.34x | ₩-25.35 Billion |
| 2022 | -6.24% | -127.79% | 0.03x | 1.48x | ₩-28.91 Billion |
| 2023 | -34.61% | -169.65% | 0.15x | 1.33x | ₩-58.54 Billion |
| 2024 | 1.58% | 5.17% | 0.26x | 1.16x | ₩-11.81 Billion |
Industry Comparison
This section compares T Scientific Co.Ltd's net assets metrics with peer companies in the Software & IT Services industry.
Industry Context
- Industry: Software & IT Services
- Average net assets among peers: $52,630,877,645
- Average return on equity (ROE) among peers: 3.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| T Scientific Co.Ltd (057680) | ₩140.08 Billion | 3.81% | 0.15x | $66.90 Million |
| Daishin Information & Communications Co.Ltd (020180) | $28.59 Billion | -0.17% | 1.98x | $32.06 Million |
| PLAYWITH Inc (023770) | $13.65 Billion | 0.00% | 1.50x | $7.73 Million |
| Hancom Inc (030520) | $151.60 Billion | 15.84% | 0.41x | $300.10 Million |
| UBcare. Co. Ltd (032620) | $43.84 Billion | 0.00% | 0.25x | $140.04 Million |
| Softcen Co. Ltd (032680) | $9.15 Billion | 11.19% | 0.68x | $5.97 Million |
| InfoBank Corporation (039290) | $52.41 Billion | 1.60% | 0.39x | $26.52 Million |
| Korea Business News Co. Ltd (039340) | $121.90 Billion | 12.32% | 0.20x | $72.70 Million |
| CUROCOM Co. Ltd (040350) | $51.56 Billion | 0.00% | 0.20x | $54.20 Million |
| Polaris Office Corp (041020) | $37.38 Billion | -26.28% | 0.15x | $125.79 Million |
| Total Soft Bank Ltd (045340) | $16.22 Billion | 18.58% | 0.65x | $38.66 Million |
About T Scientific Co.Ltd
T Scientific Co., Ltd. engages in wired/mobile communication and broadcast business in Korea and internationally. The company offers mobile broadcast service, which is enabled by Cell Broadcasting Service technology; Smart DMB that is an integrated DMB application, which enables customers to watch TV or radio with DMB-embedded smartphones, as well as various value added services through telecommu… Read more